Amgen to open Science and Innovation Centre in Hyderabad’s Genome Valley
Amgen will set up a Science and Innovation Centre in Genome Valley, joining its global network of research laboratories, with operations expected in 2027.
Amgen has announced plans for a new Science and Innovation Centre in Genome Valley, Hyderabad. The centre will become part of Amgen’s global research and development network, which spans seven research laboratories.
Scientists and technologists at the centre will work in discovery chemistry, drug metabolism and pharmacokinetics, and precision medicine, in close collaboration with Amgen’s research sites around the world. The aim is to bring experimental science together with data and digital tools to speed up the discovery and development of new medicines.
Amgen’s research leadership described the centre as a way to extend how the company combines laboratory science with data and technology, complementing its R&D base in the United States. The centre is expected to be operational in 2027.
The decision builds on Amgen’s existing technology and innovation presence in Hyderabad and strengthens Genome Valley’s position as one of the leading life sciences clusters in Asia.